Clinical Trials Browser

Completed × Fallopian Tube Neoplasms × pertuzumab × Clear all

NCT00096993 2015-06-10

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

131 enrolled 11 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms